James Wong, MD
Radiation Oncology · Morristown, NJNPI 1053350777
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,463 of the $2,241 with a category attached, or 65.3%. Reflexion Medical, Inc. accounts for 65.4% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $1,480 and has fallen 97.7% since, to $34 in 2025.
Across 29 payments — averaging $77.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Reflexion Medical, Inc.$1K
- Mevion_medical_systems_inc$402
- Elekta, Inc.$104
- Eisai Inc.$71
- Telix Pharmaceuticals$50
- Merck$28
- plus $119 from 7 others
What the payments were for
- Travel & lodging$1,46365%
- Food & beverage$77835%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Reflexion Medical, Inc. | 4 | $1,466 |
| Mevion_medical_systems_inc | 6 | $402 |
| Elekta, Inc. | 1 | $104 |
| Eisai Inc. | 5 | $71 |
| Telix Pharmaceuticals | 3 | $50 |
| Merck | 2 | $28 |
| Amgen | 2 | $28 |
| GSK | 1 | $19 |
| Boston Scientific | 1 | $17 |
| Sanofi | 1 | $15 |
| Incyte Corporation | 1 | $14 |
| Foundation Medicine, Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REFLEXION MEDICAL RADIOTHERAPY SYSTEM$1,431
- PTS250$172
- Unity$104
How this compares
$2,241 in reported general payments places this provider in the 80th percentile of 132 radiation oncology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine Hcl ViscousLidocaine Hcl | 17 | $479 |
| Gabapentin | 14 | $136 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Morristown
- Robert ColeMorristown$807
- Mona KarimMorristown$741
- Michael GreenbergCherry Hill$335K
- Glen GejermanHackensack$180K
- Marc RudoltzWest Orange$166K
- Salma JabbourNew Brunswick$163K
- Edward SoffenMonroe Twp$50K
- Adnan DanishWayne$45K
- Timothy ChenPennington$43K
- Brett LewisHackensack$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.